News

Essity's Q3 Report: Growth, Innovations, and Future Plans

Essity's Q3 Report: Growth, Innovations, and Future Plans

Essity's Third Quarter Report: Performance Insights

STOCKHOLM — Essity has released its interim report for the third quarter of 2025, showcasing critical insights into its financial performance and strategic initiatives. This report highlights organic growth, improved margins, and a robust cash flow, despite a drop in net sales.

Financial Overview of Q3 2025

During the third quarter of 2025, Essity witnessed a decline in net sales, decreasing by 4.5% to reach SEK 34,638 million, compared to SEK 36,274 million in the same period last year. Excluding the impacts of currency translation, net sales showed a slight increase of SEK 322 million. In terms of organic sales growth, the company reported an increase of 0.9%, attributed to a price/mix of 0.7% and a volume increase of 0.2%.

Profitability Metrics

Essity's EBITA grew marginally to SEK 5,152 million, reflecting the company’s resilience and strategic management. When excluding items affecting comparability (IAC), EBITA stood at SEK 5,056 million, representing a 1% decrease compared to the previous year. However, after adjusting for currency fluctuations, EBITA excluding IAC showed a notable increase of 5%, equating to SEK 278 million.

Margin Strength and Shareholder Returns

The EBITA margin excluding IAC improved by 0.5 percentage points, reaching 14.6%. Additionally, the return on capital employed (ROCE) was reported at 17.9%, reinforcing the company's efficient use of capital. Profits for the period amounted to SEK 3,358 million, with earnings per share rising to SEK 4.86.

CEO’s Insights and Strategic Initiatives

In the CEO's comments, the emphasis was placed on the positive outcomes achieved amidst challenging market dynamics. Essity is not only striving for growth but is also implementing significant organizational changes and launching a cost-savings program aimed at enhancing operational efficiency and profitability.

Innovations Driving Growth

Innovation remains a cornerstone of Essity’s growth strategy. Products tailored to meet customer and consumer needs are at the forefront of its developments. A prime example is the introduction of TENA ProSkin Stretch Day & Night, designed to streamline incontinence care, thus benefiting both healthcare providers and patients.

Measures to Enhance Growth Rate

To bolster its growth trajectory amid a complex economic environment, Essity has announced a set of strategic measures. These include decentralizing decision-making processes to heighten accountability across product categories. By simplifying the corporate structure, Essity aims to remain agile, improve customer focus, and capitalize on the most promising market opportunities.

Cost Savings Initiatives

In parallel with the organizational restructure, Essity is implementing a cost savings program targeting sales and administrative expenses while safeguarding marketing budgets. The initiative is anticipated to yield savings of around SEK 1 billion annually, with a full impact by the end of 2026, thereby supporting investments in sustainable growth.

Future Targeting and Vision

Essity aspires to reach broader audiences with its hygiene and health products, aiming to capture increased market shares while maximizing the potential of its diverse product portfolio. These strategic initiatives are poised to significantly shape the company’s future trajectory.

Invitation to Presentation

Ulrika Kolsrud, President and CEO, alongside Fredrik Rystedt, Executive Vice President and CFO, will present the interim report through a live webcast and teleconference. Interested parties are invited to tune in at the scheduled time to gain a deeper understanding of the company’s strategies and performance outlook.

Frequently Asked Questions

What were Essity's net sales for Q3 2025?

Essity's net sales for Q3 2025 were SEK 34,638 million, reflecting a 4.5% decrease.

How did Essity perform in terms of EBITA?

Essity's EBITA for Q3 2025 increased to SEK 5,152 million, showcasing its resilience in the market.

What innovations did Essity launch during this quarter?

Essity launched TENA ProSkin Stretch Day & Night, a new incontinence product tailored for ease of use.

What measures is Essity taking to enhance profitability?

Essity is decentralizing decision-making and launching a cost savings program with expected annual savings of SEK 1 billion.

Who will present the interim report?

The interim report will be presented by Ulrika Kolsrud, President and CEO, and CFO Fredrik Rystedt.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 86

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 70

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 78

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 11

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 30

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 165

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 121

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 39

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 275

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Matt Hougan Shares Insights on Bitcoin's Potential Surge

Updated Category News Views 165

Understanding Bitcoin's Growth Potential Matt Hougan, the Chief Investment Officer at Bitwise, sheds light on the driving forces behind the burgeoning interest in Bitcoin. He emphasizes concerns over the decline of fiat currencies and noteworthy inflows into Bitcoin ETFs as the catalysts propelling Bitcoin's journey towards new heights. This surge towards potential record...

Continue Reading
Empowering Futures: Access Bank's Commitment to Education

Updated Category News Views 174

Support for Educational Development In recent years, The Access Bank UK Ltd has made significant strides in supporting educational initiatives aimed at transforming lives. This commitment is exemplified by the annual Polo Cup event that they host in collaboration with UNICEF and Fifth Chukker. The Access Bank Cup has become more than just a sporting affair; it is a beacon...

Continue Reading
Gary Brecka's Event Redefines Longevity's Future in L.A.

Updated Category News Views 46

Exploring Longevity: A Day Like No Other Alright, picture this: a convergence of wellness diehards, human performance buffs, and curious minds, all filing into the Peacock Theater in Los Angeles. It's August 16th and they're here for Gary Brecka LIVE. This is no run-of-the-mill wellness seminar; it's an exclusive deep dive into the world of longevity hosted by Sequel...

Continue Reading
Ultragenyx Pharmaceutical and Others Face Challenges in Ratings

Updated Category News Views 164

Stock Market Overview This morning, U.S. stock futures indicated a downward trend, with the Dow futures decreasing by about 100 points. Given the numerous fluctuations in the market recently, this drop is indicative of the challenges many companies are facing. Ultragenyx Pharmaceutical Inc Performance Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have sharply...

Continue Reading
Netflix's Future: Overcoming Slower Subscriber Growth Strategies

Updated Category News Views 185

Analyzing Netflix's Subscription Growth and Future Strategies Netflix, a leading name in streaming services, is facing a potential slowdown in subscriber additions. Analysts suggest that the streaming giant might experience its most modest subscriber growth in the past six quarters as the gains from its recent password-sharing crackdown start to wane. With this shifting...

Continue Reading